表紙
市場調査レポート

ニコチン中毒:世界の治験レビュー

Nicotine Addiction Global Clinical Trials Review, H1, 2015

発行 GlobalData 商品コード 232277
出版日 ページ情報 英文 81 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。
Back to Top
ニコチン中毒:世界の治験レビュー Nicotine Addiction Global Clinical Trials Review, H1, 2015
出版日: 2015年02月27日 ページ情報: 英文 81 Pages
概要

当レポートでは、ニコチン中毒の治療薬に関する治験について調査分析し、最新動向、段階別・相別の状況、有望企業、開発中の治療薬の情報、治験プロファイルなどについて、体系的な情報を提供しています。

目次

イントロダクション

地域別の治験

  • 国別の治験動向
    • アジア太平洋地域の主要国
    • 欧州の主要国
    • 北米の主要国
    • 中東・アフリカの主要国
    • 中南米の主要国

G7諸国における治験:中枢神経系の治験に対するニコチン中毒の割合

G7諸国における治験:相別

G7諸国における治験:段階別

E7諸国における治験:中枢神経系の治験に対するニコチン中毒の割合

E7諸国における治験:相別

E7諸国における治験:段階別

相別の治験

段階別の治験

評価項目別の治験

未完了の治験

一定期間に採用された被験者

スポンサータイプ別の治験

有望なスポンサー

  • ニコチン中毒の治療薬の治験に参加している主要企業

有望薬

治験プロファイル

  • 主要企業の治験概要
    • Johnson & Johnson
    • Pfizer Inc.
    • GlaxoSmithKline plc
    • Nabi Biopharmaceuticals (休止中)
    • Omeros Corporation
    • Star Scientific, Inc.
    • Rock Creek Pharmaceuticals INC
    • FORUM Pharmac
  • 主要大学・研究機関・病院の治験概要
    • National Institute on Drug Abuse
    • University of Pennsylvania
    • Yale University
    • Mayo Clinic
    • Centre for Addiction and Mental Health
    • University of Wisconsin Madison
    • Mclean Hospital
    • Massachusetts General Hospital
    • Duke University
    • University of California, San Francisco

主な臨床プロファイル

付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC2574CTIDB

GlobalData's clinical trial report, "Nicotine Addiction Global Clinical Trials Review, H1, 2015" provides data on the Nicotine Addiction clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Nicotine Addiction. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Nicotine Addiction. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Nicotine Addiction
    • Report Guidance
  • Clinical Trials by Region
  • Clinical Trials and Average Enrollment by Country
    • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
    • Top Five Countries Contributing to Clinical Trials in Europe
    • Top Countries Contributing to Clinical Trials in North America
    • Top Countries Contributing to Clinical Trials in Middle East and Africa
    • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Nicotine Addiction to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Nicotine Addiction to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Nicotine Addiction
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Nicotine Addiction Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Johnson & Johnson
      • Clinical Trial Overview of Johnson & Johnson
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • Nabi Biopharmaceuticals (Inactive)
      • Clinical Trial Overview of Nabi Biopharmaceuticals (Inactive)
      • Omeros Corporation
      • Clinical Trial Overview of Omeros Corporation
      • Star Scientific, Inc.
      • Clinical Trial Overview of Star Scientific, Inc.
      • Rock Creek Pharmaceuticals INC
      • Clinical Trial Overview of Rock Creek Pharmaceuticals INC
      • FORUM Pharmaceuticals Inc.
      • Clinical Trial Overview of FORUM Pharmaceuticals Inc.
      • Bioprojet SCR
      • Clinical Trial Overview of Bioprojet SCR
    • Clinical Trial Overview of Top Institutes / Government
      • National Institute on Drug Abuse
      • Clinical Trial Overview of National Institute on Drug Abuse
      • University of Pennsylvania
      • Clinical Trial Overview of University of Pennsylvania
      • Yale University
      • Clinical Trial Overview of Yale University
      • Mayo Clinic
      • Clinical Trial Overview of Mayo Clinic
      • Centre for Addiction and Mental Health
      • Clinical Trial Overview of Centre for Addiction and Mental Health
      • University of Wisconsin Madison
      • Clinical Trial Overview of University of Wisconsin Madison
      • Mclean Hospital
      • Clinical Trial Overview of Mclean Hospital
      • Massachusetts General Hospital
      • Clinical Trial Overview of Massachusetts General Hospital
      • Duke University
      • Clinical Trial Overview of Duke University
      • University of California, San Francisco
      • Clinical Trial Overview of University of California, San Francisco
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Nicotine Addiction Therapeutics, Global, Clinical Trials by Region, 2015*
  • Nicotine Addiction Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Nicotine Addiction Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Nicotine Addiction Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
  • Nicotine Addiction Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Nicotine Addiction Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Nicotine Addiction Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015*
  • Nicotine Addiction Therapeutics Clinical Trials, Central and South America, Top Countries, 2015*
  • Proportion of Nicotine Addiction to Central Nervous System Clinical Trials, G7 Countries (%), 2015*
  • Nicotine Addiction Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Nicotine Addiction Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Nicotine Addiction to Central Nervous System Clinical Trials, E7 Countries (%), 2015*
  • Nicotine Addiction Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Nicotine Addiction Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Nicotine Addiction Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Nicotine Addiction Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Nicotine Addiction Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Nicotine Addiction Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Nicotine Addiction Therapeutics, Global, Suspended Clinical Trials, 2015*
  • Nicotine Addiction Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Nicotine Addiction Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Nicotine Addiction Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Nicotine Addiction Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Nicotine Addiction Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Nicotine Addiction Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Nicotine Addiction Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2015*
  • Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015*
  • Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2015*
  • Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Nabi Biopharmaceuticals (Inactive), 2015*
  • Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Omeros Corporation, 2015*
  • Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Star Scientific, Inc., 2015*
  • Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Rock Creek Pharmaceuticals INC, 2015*
  • Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by FORUM Pharmaceuticals Inc., 2015*
  • Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Bioprojet SCR, 2015*
  • Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute on Drug Abuse, 2015*
  • Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2015*
  • Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Yale University, 2015*
  • Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2015*
  • Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre for Addiction and Mental Health, 2015*
  • Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Wisconsin Madison, 2015*
  • Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Mclean Hospital, 2015*
  • Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2015*
  • Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2015*
  • Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2015*

List of Figures

  • Nicotine Addiction Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Nicotine Addiction Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Nicotine Addiction Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Nicotine Addiction Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
  • Nicotine Addiction Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Nicotine Addiction Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Proportion of Nicotine Addiction to Central Nervous System Clinical Trials, G7 Countries (%), 2015*
  • Nicotine Addiction Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Nicotine Addiction Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Nicotine Addiction to Central Nervous System Clinical Trials, E7 Countries (%), 2015*
  • Nicotine Addiction Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Nicotine Addiction Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Nicotine Addiction Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Nicotine Addiction Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Nicotine Addiction Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Nicotine Addiction Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Nicotine Addiction Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Nicotine Addiction Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Nicotine Addiction Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Nicotine Addiction Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Nicotine Addiction Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top